Neurotrophism, mitogenesis, and nerve regeneration as models for neuropeptide mediation. Introduction to Part VI.
Brenneman
D E
DE
Section on Developmental and Molecular Pharmacology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
D000818:Animals; D002455:Cell Division; D006801:Humans; D008959:Models, Neurological; D009416:Nerve Regeneration; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D009479:Neuropeptides / Q000494:pharmacology / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000502:physiology; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D018013:Receptors, Neuropeptide / Q000096:biosynthesis / Q000502:physiology; D014660:Vasoactive Intestinal Peptide / Q000502:physiology
C495401:ADCYAP1 protein, human; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D018013:Receptors, Neuropeptide; D014660:Vasoactive Intestinal Peptide